Literature DB >> 20595152

Factors associated with inflammatory cytokine patterns in community-acquired pneumonia.

R Martínez1, R Menéndez, S Reyes, E Polverino, C Cillóniz, A Martínez, C Esquinas, X Filella, P Ramírez, A Torres.   

Abstract

Raised systemic levels of interleukin (IL)-6 and IL-10 cytokines have been associated with poorer outcome in community-acquired pneumonia. The aim of our study was to identify potential associated factors with increased levels of IL-6, IL-10, or both cytokines. We performed a prospective study of 685 patients admitted to hospital with community-acquired pneumonia. IL-6 and IL-10 were measured in blood in the first 24 h. 30-day mortality increased from 4.8% to 11.4% (p = 0.003) when both cytokines were higher than the median. Independent associated factors with an excess of IL-6 were neurologic disease, confusion, serum sodium < 130 mEq·L⁻¹, pleural effusion, and bacteraemia. The associated factors for an excess of IL-10 were respiratory rate ≥ 30 breaths·min⁻¹, systolic blood pressure < 90 mmHg and glycaemia ≥ 250 mg·dL⁻¹. The independent associated factors for an excess of both cytokines were confusion, systolic blood pressure < 90 mmHg, pleural effusion and bacteraemia. Protective factors were prior antibiotic treatment and pneumococcal vaccination. Different independent factors are related to an excess of IL-6 and IL-10. Confusion, hypotension, pleural effusion and bacteraemia were associated with the inflammatory profile with the highest mortality rate, whereas anti-pneumococcal vaccination and previous antibiotic treatment appeared to be protective factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20595152     DOI: 10.1183/09031936.00040710

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  25 in total

1.  IL-10-producing NK cells exacerbate sublethal Streptococcus pneumoniae infection in the lung.

Authors:  Sarah E Clark; Rebecca L Schmidt; Elizabeth R Aguilera; Laurel L Lenz
Journal:  Transl Res       Date:  2020-07-04       Impact factor: 7.012

2.  Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia.

Authors:  Clarissa Valim; Rushdy Ahmad; Miguel Lanaspa; Yan Tan; Sozinho Acácio; Michael A Gillette; Katherine D Almendinger; Danny A Milner; Lola Madrid; Karell Pellé; Jaroslaw Harezlak; Jacob Silterra; Pedro L Alonso; Steven A Carr; Jill P Mesirov; Dyann F Wirth; Roger C Wiegand; Quique Bassat
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

3.  Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.

Authors:  Stephen M Pastores; Djillali Annane; Bram Rochwerg
Journal:  Intensive Care Med       Date:  2017-10-31       Impact factor: 17.440

4.  Vitamin D Promotes Pneumococcal Killing and Modulates Inflammatory Responses in Primary Human Neutrophils.

Authors:  Karthik Subramanian; Peter Bergman; Birgitta Henriques-Normark
Journal:  J Innate Immun       Date:  2017-02-28       Impact factor: 7.349

Review 5.  Inhaled corticosteroids and the increased risk of pneumonia: what's new? A 2015 updated review.

Authors:  Hernan Iannella; Carlos Luna; Grant Waterer
Journal:  Ther Adv Respir Dis       Date:  2016-02-18       Impact factor: 4.031

6.  Excess healthcare spending associated with fractures among adults with cerebral palsy.

Authors:  Daniel G Whitney; Michelle S Caird; Karl J Jepsen; Edward A Hurvitz; Richard A Hirth
Journal:  Disabil Health J       Date:  2022-03-10       Impact factor: 4.615

Review 7.  Adjunct corticosteroid treatment in patients with pneumonia: A precision medicine approach.

Authors:  Srdjan Gavrilovic; Ana Andrijevic; Aida Mujakovic; Yewande Odeyemi; Belma Paralija; Ognjen Gajic
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

8.  Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis.

Authors:  Wei Nie; Yi Zhang; Jinwei Cheng; Qingyu Xiu
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia.

Authors:  Cornelis P C de Jager; Peter C Wever; Eugenie F A Gemen; Ron Kusters; Arianne B van Gageldonk-Lafeber; Tom van der Poll; Robert J F Laheij
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

10.  Cytokines and chemokines as biomarkers of community-acquired bacterial infection.

Authors:  Michal Holub; David A Lawrence; Nancy Andersen; Alžběta Davidová; Ondřej Beran; Vilma Marešová; Pavel Chalupa
Journal:  Mediators Inflamm       Date:  2013-04-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.